Antimicrobial Foaming Soap Recall Issued in Canada Due to Contamination

|

A Canadian based company is recalling one lot of its antimicrobial hand soap, due to potential concerns that over contamination that may pose serious health risks to consumers, especially individuals with weakened or compromised immune systems.ย 

The Avmor Ltd. Antimicrobial Foaming Hand Soap (Triclosan 0.3%) recall was announced October 15, after standard product testing by Health Canada detected pseudomonas aeruginosa, which is a bacterium most known to cause infections of the eye and outer ear.

The hand soap was sold under the Avmor Ltd. name brand in one-liter clear plastic cartridges, to be used with a foaming pump for both private and public settings. Recalled soaps have drug identification number (DIN) 02319144 and lot number F121392032. Avmor Ltd. warned that people should not use the hand soap if it is unidentifiable.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

This soap was distributed throughout Canada, with some of the product going to Atlantic Canada, Ontario, Quebec, and British Columbia. To date, no reports of adverse reactions have been reported to Avmor Ltd. but if consumers believed they may have used the product they should report to their healthcare practitioner.

Pseudomonas group bacteria enter healthy individuals usually through cuts, lesions, and open wounds causing infections, abscesses, and blood infections.

Individuals most affected by the pseudomonas group are those with compromised immune systems from cystic fibrosis, HIV/AIDS, cancer, burns, diabetes and severe lung disease because it leaves them more vulnerable to serious infections such as pneumonia, bone infections, urinary tract infections, meningitis, and gastrointestinal infections.

Russell Maas
Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโ€™s leading personal injury law firms and oversees the siteโ€™s editorial strategy, including SEO and content development.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.
A California woman’s Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug’s cancer risks, but refused to inform doctors and patients.
A FanDuel addiction lawsuit claims a Pennsylvania man wagered massive amounts of money after being subjected to a tailored promotional campaign designed to exploit his gambling habits.